Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Cited by (1,000)

Items 101–200 of 1,000

1. Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
   Raygene Martier, Pavlina S. Konstantinova · 2020 · Frontiers in Neuroscience
2. Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
   Stephan Riesenberg, Philipp Kanis, Dominik Macak, Damian Wollny, Dorothee Düsterhöft, Johannes Kowalewski, Nelly Helmbrecht, Tomislav Maričić, Svante Pääbo · 2023 · Nature Methods
3. Precise genome-wide base editing by the CRISPR Nickase system in yeast
   Atsushi Satomura, Ryosuke Nishioka, Hitoshi Mori, Kosuke Sato, Kouichi Kuroda, Mitsuyoshi Ueda · 2017 · Scientific Reports
4. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis
   Francesca De Giorgio, Cheryl Maduro, Elizabeth Fisher, Abraham Acevedo‐Arozena · 2019 · Disease Models & Mechanisms
5. Advances in CRISPR-Cas technology and its applications: revolutionising precision medicine
   Sarkar Sardar Azeez, Rahin Shareef Hamad, BahraK Hamad, Mudhir Sabir Shekha, Peter Bergsten · 2024 · Frontiers in Genome Editing
6. Genome editing in crop improvement: Present scenario and future prospects
   Gurbachan S. Miglani · 2017 · Journal of Crop Improvement
7. Unraveling the functional role of DNA demethylation at specific promoters by targeted steric blockage of DNA methyltransferase with CRISPR/dCas9
   Daniel M. Sapozhnikov, Moshe Szyf · 2021 · Nature Communications
8. BRAFV600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts
   Daofu Feng, Bo Qin, Krishnendu Pal, Lei Sun, Shamit Kumar Dutta, Haidong Dong, Xin Liu, Debabrata Mukhopadhyay, Shengbing Huang, Frank A. Sinicrope · 2019 · Oncogene
9. Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
   Song Hee Jeong, Ho Joung Lee, Sang Jun Lee · 2023 · The Journal of Microbiology
10. Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints
    Qinchang Chen, Guohui Chuai, Haihang Zhang, Jin Tang, Liwen Duan, Huan Guan, Wenhui Li, Wannian Li, Jiaying Wen, Erwei Zuo et al. · 2023 · Nature Communications
11. Progress and Challenges for Live-Cell Imaging of Genomic Loci using CRISPR-Based Platforms
    Xiaotian Wu, Shiqi Mao, Yachen Ying, Christopher J. Krueger, Antony K. Chen · 2019 · Genomics Proteomics & Bioinformatics
12. Eliminating mcr-1-harbouring plasmids in clinical isolates using the CRISPR/Cas9 system
    Pengxia Wang, Dongmei He, Baiyuan Li, Yunxue Guo, Weiquan Wang, Xiong‐Jian Luo, Xuanyu Zhao, Xiaoxue Wang · 2019 · Journal of Antimicrobial Chemotherapy
13. Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
    Qianqian Gao, Xuan Dong, Qumiao Xu, Linnan Zhu, Fei Wang, Yong Hou, Cheng‐Chi Chao · 2019 · Cancer Medicine
14. CRISPR Therapeutics for Duchenne Muscular Dystrophy
    Esra J. N. Erkut, Toshifumi Yokota · 2022 · International Journal of Molecular Sciences
15. Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
    Agnieszka Łoboda, Józef Dulak · 2020 · Pharmacological Reports
16. Revolutionizing CRISPR technology with artificial intelligence
    Min‐Gyeong Kim, Min-ji Go, Seung-Hun Kang, Soo-hwan Jeong, Kayeong Lim · 2025 · Experimental & Molecular Medicine
17. Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation
    Chih‐Che Shen, Mu‐Nung Hsu, Chin-Wei Chang, Mei‐Wei Lin, Jih Ru Hwu, Yi Tu, Yu‐Chen Hu · 2018 · Nucleic Acids Research
18. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment
    Chunyang Jiang, Lingxiang Meng, Bingjun Yang, Xin Luo · 2019 · Clinical Genetics
19. Towards accurate and reliable resolution of structural variants for clinical diagnosis
    Zhichao Liu, Ruth Angela Roberts, Tim R. Mercer, Joshua Xu, Fritz Joachim Sedlazeck, Weida Tong · 2022 · Genome biology
20. CRISPR/Cas9 system in breast cancer therapy: advancement, limitations and future scope
    Vamika Karn, Sandhya Sandhya, Wayne Hsu, Deepak Parashar, Himanshu Narayan Singh, Niraj Kumar Jha, Saurabh K. Gupta, Navneet Kumar Dubey, Sanjay Kumar · 2022 · Cancer Cell International
21. Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells
    Michael Hiltensperger, Angela M. Krackhardt · 2023 · Frontiers in Immunology
22. Broadening the GMO risk assessment in the EU for genome editing technologies in agriculture
    Katharina Kawall, Janet D. Cotter-Howells, Christoph Then · 2020 · Environmental Sciences Europe
23. CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
    Mohammadreza Azangou‐Khyavy, Mobina Ghasemi, Javad Khanali, Melika Boroomand-Saboor, Monire Jamalkhah, Masoud Soleimani, Jafar Kiani · 2020 · Frontiers in Immunology
24. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro
    Katharina E. Meijboom, Abbas Abdallah, Nicholas P. Fordham, Hiroko Nagase, Tomás Rodríguez, Carolyn Kraus, Tania F. Gendron, Gopinath Krishnan, Rustam Esanov, Nadja S. Andrade et al. · 2022 · Nature Communications
25. CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
    Debarati Ghosh, Prabhadevi Venkataramani, Saikat Nandi, Sonali Bhattacharjee · 2019 · Cancer Cell International
26. Cell-type-specific epigenetic effects of early life stress on the brain
    Rahman, Mouly F., McGowan, Patrick O. · 2022 · Translational Psychiatry
27. Keeping crispr in check: diverse mechanisms of phage-encoded anti- crisprs
    Despoina Trasanidou, Ana Sousa Gerós, Prarthana Mohanraju, Anna Cornelia Nieuwenweg, Franklin L. Nóbrega, Raymond H.J. Staals · 2019 · FEMS Microbiology Letters
28. Ethical Issues in Genome Editing using Crispr/Cas9 System
    Eduardo Rodrı́guez · 2016 · Journal of Clinical Research & Bioethics
29. Concise Review: Assessing the Genome Integrity of Human Induced Pluripotent Stem Cells: What Quality Control Metrics?
    Assou, Said, Bouckenheimer, Julien, De Vos, John · 2018 · Stem Cells
30. Direct identification of antibiotic resistance genes on single plasmid molecules using CRISPR/Cas9 in combination with optical DNA mapping
    Vilhelm Müller, Fredrika Rajer, Karolin Frykholm, Lena K. Nyberg, Saair Quaderi, Joachim Fritzsche, Erik Kristiansson, Tobias Ambjörnsson, Linus Sandegren, Fredrik Westerlund · 2016 · Scientific Reports
31. CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms
    Muhammad Rizwan Javed, Maria Sadaf, Temoor Ahmed, Amna Jamil, Marium Nawaz, Hira Abbas, Anam Ijaz · 2018 · Current Microbiology
32. Recent Advances in the Application of CRISPR/Cas9 Gene Editing System in Poultry Species
    Collins N. Khwatenge, Samuel N. Nahashon · 2021 · Frontiers in Genetics
33. CRISPR/Cas- and Topical RNAi-Based Technologies for Crop Management and Improvement: Reviewing the Risk Assessment and Challenges Towards a More Sustainable Agriculture
    Fabiano T. P. K. Távora, Francisco de Assis dos Santos Diniz, Camila M. Rêgo-Machado, Natália Chagas Freitas, Fabrício Barbosa Monteiro Arraes, Eduardo Chumbinho de Andrade, Leila Lourenço Furtado, Karen Ofuji Osiro, Natália Lima de Sousa, Thiago Bergamo Cardoso et al. · 2022 · Frontiers in Bioengineering and Biotechnology
34. Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
    Turner, Thomas J., Zourray, Clara, Schorge, Stephanie, Lignani, Gabriele · 2021 · Journal of Neurochemistry
35. Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System
    Jenny Shapiro, Ortal Iancu, Ashley M. Jacobi, Matthew McNeill, Rolf Turk, Garrett R. Rettig, Ido Amit, Adi Tovin, Zohar Yakhini, Mark A. Behlke et al. · 2020 · Molecular Therapy — Methods & Clinical Development
36. Plant Viruses: From Targets to Tools for CRISPR
    Carla Marisa Reis Varanda, Maria do Rosário Félix, Maria Doroteia Campos, Mariana Patanita, Patrick Materatski · 2021 · Viruses
37. New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin
    Konstantin A. Senkevich, Uladzislau Rudakou, Ziv Gan‐Or · 2021 · Neuropharmacology
38. A CRISPR-Cas Cure for HIV/AIDS
    Mouraya Hussein, Mariano A. Molina, Ben Berkhout, Elena Herrera-Carrillo · 2023 · International Journal of Molecular Sciences
39. Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management
    Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Fahd Khaleefah Alkhaleefah, Arshad Husain Rahmani, Amjad Ali Khan · 2022 · 癌症：英文版
40. Enhancement of red blood cell transfusion compatibility using CRISPR‐mediated erythroblast gene editing
    Joseph Hawksworth, Timothy J. Satchwell, Marjolein Meinders, Deborah E. Daniels, Fiona A. M. Regan, Nicole M. Thornton, Marieangela C. Wilson, Johannes G. G. Dobbe, Geert J. Streekstra, Kongtana Trakarnsanga et al. · 2018 · EMBO Molecular Medicine
41. Perspectives in primary hyperoxaluria — historical, current and future clinical interventions
    Kevin Shee, Marshall L. Stoller · 2021 · Nature Reviews Urology
42. Fine-Tuning Next-Generation Genome Editing Tools
    Chidananda Nagamangala Kanchiswamy, Massimo Emilio Maffei, Mickaël Malnoy, Riccardo Velasco, Jin‐Soo Kim · 2016 · Trends in biotechnology
43. Flavonoids as key players in cold tolerance: molecular insights and applications in horticultural crops
    Jiaxin Li, Qinhan Yu, Chang Liu, Ningbo Zhang, Weirong Xu · 2024 · Horticulture Research
44. Evolution of Hybridization Probes to DNA Machines and Robots
    Dmitry M. Kolpashchikov · 2019 · Accounts of Chemical Research
45. CRISPR-Mediated Protein Tagging with Nanoluciferase to Investigate Native Chemokine Receptor Function and Conformational Changes
    Carl W. White, Birgit Caspar, Hannah Kate Vanyai, Kevin D. G. Pfleger, Stephen J. Hill · 2020 · Cell chemical biology
46. Precise and efficient silencing of mutant KrasG12D by CRISPR-CasRx controls pancreatic cancer progression
    Wang Jiang, Hao Li, Xiyu Liu, Jianping Zhang, Wuhu Zhang, Tianjiao Li, Liang Liu, Xianjun Yu · 2020 · Theranostics
47. Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
    Xiaoqiang Huang, Dongshan Yang, Jifeng Zhang, Jie Xu, Y. Eugene Chen · 2022 · Cells
48. Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives
    Michela Palmieri, Diego Pozzer, Nicoletta Landsberger · 2023 · Frontiers in Neuroscience
49. Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
    Ke Yi, Huimin Kong, Yeh‐Hsing Lao, Di Li, Rachel L. Mintz, Tianxu Fang, Guojun Chen, Yu Tao, Mingqiang Li, Jianxun Ding · 2023 · Advanced Materials
50. Evolution of CRISPR/Cas Systems for Precise Genome Editing
    Magdalena Hryhorowicz, Daniel Lipiński, Joanna Zeyland · 2023 · International Journal of Molecular Sciences
51. Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review
    Arun Kumar Dangi, Rajeshwari Sinha, Shailja Dwivedi, Sanjeev Kumar Gupta, Pratyoosh Shukla · 2018 · Frontiers in Pharmacology
52. RNA-targeting CRISPR systems from metagenomic discovery to transcriptomic engineering
    Aaron A. Smargon, Yilan J. Shi, Gene Wei-Ming Yeo · 2020 · Nature Cell Biology
53. Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework
    Marta A. B. R. Carvalho, Bruno Miguel Nogueira Sepodes, Ana Paula Martins · 2017 · Frontiers in Medicine
54. Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders
    Jason W. Adams, Fernanda R. Cugola, Alysson Renato Muotri · 2019 · Physiology
55. Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2
    Annabel K. Sangree, Audrey L Griffith, Zsofia M Szegletes, Priyanka Roy, Peter C. DeWeirdt, Mudra Hegde, Abby V. McGee, Ruth E. Hanna, John G. Doench · 2022 · Nature Communications
56. Risk and safety considerations of genome edited crops: Expert opinion
    Rim Lassoued, Diego Maximiliano Macall, Stuart J. Smyth, Peter W.B. Phillips, Hayley Hesseln · 2019 · Current Research in Biotechnology
57. Impact of CRISPR-Cas9-Based Genome Engineering in Farm Animals
    Parul Singh, Syed Azmal Ali · 2021 · Veterinary Sciences
58. Recent advances in therapeutic gene-editing technologies
    Dongqi Liu, Di Cao, Renzhi Han · 2025 · Molecular Therapy
59. An Overview of CRISPR-Based Tools and Their Improvements: New Opportunities in Understanding Plant–Pathogen Interactions for Better Crop Protection
    Abdellah Barakate, Jennifer Stephens · 2016 · Frontiers in Plant Science
60. Safe harbor-targeted CRISPR-Cas9 homology-independent targeted integration for multimodality reporter gene-based cell tracking
    John Joseph Kelly, Moe Saee-Marand, Nivin N. Nyström, Melissa M Evans, Yuanxin Chen, Francisco M. Martínez, Amanda M. Hamilton, John Andrew Ronald · 2021 · Science Advances
61. Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
    Andrew C. Berical, Rhianna E. Lee, Scott H. Randell, Finn J Hawkins · 2019 · Frontiers in Pharmacology
62. Combinatorial metabolic engineering of Escherichia coli for de novo production of 2′-fucosyllactose
    Lu Lin, Mengyue Gong, Yanfeng Liu, Jianghua Li, Xueqin Lv, Guocheng Du, Long Liu · 2022 · Bioresource Technology
63. CRISPR /Cas‐based tools for the targeted control of plant viruses
    Gaëlle Robertson, Johan Theodorus Burger, Manuela Campa · 2022 · Molecular Plant Pathology
64. CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment
    Klaudia Bonowicz, Dominika Jerka, Klaudia Piekarska, Janet Olagbaju, Laura Stapleton, Munirat Shobowale, Andrzej Bartosiński, Magdalena Łapot, Yidong Bai, Maciej Gagat · 2025 · Cells
65. Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer
    Chunyang Jiang, Xiaohui Lin, Zhigang Zhao · 2019 · Trends in Molecular Medicine
66. Current progress of genome editing in livestock
    Kiho Lee, Kyungjun Uh, Kayla Farrell · 2020 · Theriogenology
67. Evolution and Application of Genome Editing Techniques for Achieving Food and Nutritional Security
    Sajid Fiaz, Sunny Ahmar, Sajjad Saeed, Aamir Riaz, Freddy Mora, Ki‐Hong Jung · 2021 · International Journal of Molecular Sciences
68. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
    Paula Germino-Watnick, Malikiya Hinds, Anh Le, Rebecca Chu, Xiong Liu, Naoya Uchida · 2022 · Cells
69. SOX2 Activation Using CRISPR/dCas9 Promotes Wound Healing in Corneal Endothelial Cells
    Yoon Kyung Chang, Jin Sun Hwang, Tae‐Young Chung, Young Joo Shin · 2018 · Stem Cells
70. Target-dependent nickase activities of the CRISPR–Cas nucleases Cpf1 and Cas9
    Becky Xu Hua Fu, Justin Smith, Ryan T. Fuchs, Megumu Yamada Mabuchi, Jennifer L. Curcuru, G. Brett Robb, Andrew Z. Fire · 2019 · Nature Microbiology
71. Progresses, Challenges, and Prospects of Genome Editing in Soybean (Glycine max)
    Hu Xu, Lixiao Zhang, Kang Zhang, Yidong Ran · 2020 · Frontiers in Plant Science
72. Characterizing Endogenous Protein Complexes with Biological Mass Spectrometry
    Rivkah Rogawski, Michal Sharon · 2021 · Chemical Reviews
73. CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders
    Lihong Guan, Yawei Han, Ciqing Yang, Suxiang Lu, Jiang Du, Han Li, Juntang Lin · 2021 · Molecular Neurobiology
74. Gene-Based Therapeutics for Inherited Retinal Diseases
    Beau James Fenner, Tien‐En Tan, Veluchamy A. Barathi, Sai Bo Bo Tun, Sia Wey Yeo, Andrew S. H. Tsai, Shu Yen Lee, Chui Ming Gemmy Cheung, Choi Mun Chan, Jodhbir Singh Mehta et al. · 2022 · Frontiers in Genetics
75. Nanobiomaterial vectors for improving gene editing and gene therapy
    Shao Wei Hu, Tao Ding, Honghai Tang, Huiping Guo, Wenguo Cui, Yilai Shu · 2023 · Materials Today
76. Integrating machine learning and genome editing for crop improvement
    Long Chen, Guanqing Liu, Tao Zhang · 2024 · aBIOTECH
77. Reversal of mcr-1-Mediated Colistin Resistance in Escherichia coli by CRISPR-Cas9 System
    Peng Wan, Shiyun Cui, Zhen-Bao Ma, Lin Chen, Xiaoshen Li, Ruonan Zhao, Wenguang Xiong, Zhenling Zeng · 2020 · Infection and Drug Resistance
78. ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
    Julian Boutin, David Cappellen, Juliette Rosier, Samuel Amintas, Sandrine Dabernat, Aurélie Bedel, François Moreau‐Gaudry · 2022 · The CRISPR Journal
79. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR‐associated genome‐editing toolkit to enhance salt stress tolerance in rice and wheat
    Romaan Nazir, Sayanti Mandal, Sicon Mitra, Mimosa Ghorai, Neela Das, Niraj Kumar Jha, Madhumita Majumder, Devendra Kumar Pandey, Abhijit Dey · 2022 · Physiologia Plantarum
80. CRISPR/Cas mediated epigenome editing for cancer therapy
    Imran Ansari, Animesh Chaturvedi, Deepak Chitkara, Saurabh Pratap Singh · 2021 · Seminars in Cancer Biology
81. Accurate deep learning off-target prediction with novel sgRNA-DNA sequence encoding in CRISPR-Cas9 gene editing
    Jérémy Charlier, Robert Nadon, Vladimir Makarenkov · 2021 · Bioinformatics
82. Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity
    Rongjie Fu, Wei He, Jinzhuang Dou, Oscar David Villarreal, Ella Bedford, Helen H. Wang, Connie Hou, Liang Zhang, Yalong Wang, Dacheng Ma et al. · 2022 · Nature Communications
83. Next-generation cell therapies: the emerging role of CAR-NK cells
    Rafet Başar, May Daher, Katayoun Rezvani · 2020 · Hematology
84. Metabolic engineering of bacterial strains using CRISPR/Cas9 systems for biosynthesis of value-added products
    Ernest Fokum, Hossain M. Zabed, Qi Jin Guo, Junhua Yun, Miaomiao Yang, Hao Pang, Yingfeng An, Wen Li, Xianghui Qi · 2019 · Food Bioscience
85. CRISPR/Cas9 mediated mutagenesis of MORE AXILLARY GROWTH 1 in tomato confers resistance to root parasitic weed Phelipanche aegyptiaca
    Vinay Kumar Bari, Jackline Abu Nassar, Radi Aly · 2021 · Scientific Reports
86. In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
    Kun Lun Huang, Daniel A. Zapata, Yan Tang, Yong Teng, Yamin Li · 2022 · Biomaterials
87. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
    Goldie V. Roth, Isabella R. Gengaro, Lei S. Qi · 2024 · Cell chemical biology
88. Emerging Strategies in TCR-Engineered T Cells
    Wei Fang, Xiaoxia Cheng, John Zhao Xue, Shao‐An Xue · 2022 · Frontiers in Immunology
89. Applications of CRISPR-Cas9 in Alzheimer’s Disease and Related Disorders
    Laura Maria De Plano, Giovanna Calabrese, Sabrina Conoci A, Salvatore P. P. Guglielmino, Salvatore Oddo, Antonella Caccamo · 2022 · International Journal of Molecular Sciences
90. Cell Reprogramming With CRISPR/Cas9 Based Transcriptional Regulation Systems
    К. М. Шакирова, Viktoriia Y. Ovchinnikova, Erdem Bairovich Dashinimaev · 2020 · Frontiers in Bioengineering and Biotechnology
91. CRISPR-based strategies in infectious disease diagnosis and therapy
    Alexandra Binnie, Emanuel Fernandes, Hélder Almeida-Lousada, Ramon Andrade de Mello, Pedro Castelo‐Branco · 2021 · Infection
92. CRISPR-Cas9: A fascinating journey from bacterial immune system to human gene editing
    Munshi Azad Hossain · 2021 · Progress in molecular biology and translational science
93. An efficient method for generation of bi-allelic null mutant mouse embryonic stem cells and its application for investigating epigenetic modifiers
    Cynthia L. Fisher, Hendrik Marks, Lily T. Y. Cho, Robert Andrews, Sam Wormald, Thomas D. Carroll, Vivek Iyer, Peri H. Tate, Barry P. Rosen, Hendrik G. Stunnenberg et al. · 2017 · Nucleic Acids Research
94. Functional disruption of cell wall invertase inhibitor by genome editing increases sugar content of tomato fruit without decrease fruit weight
    Kohei Kawaguchi, Rie Takei-Hoshi, Ikue Yoshikawa, Keiji Nishida, Makoto Kobayashi, Miyako Kusano, Yu Lu, Tohru Ariizumi, Hiroshi Ezura, Shungo Otagaki et al. · 2021 · Scientific Reports
95. Age‐related macular degeneration: A disease of extracellular complement amplification
    Sarah de Jong, Jiaqi Tang, Simon J. Clark · 2022 · Immunological Reviews
96. Loop-Mediated Isothermal Amplification-Integrated CRISPR Methods for Infectious Disease Diagnosis at Point of Care
    Defne Yigci, Nazente Atçeken, Ali K. Yetisen, Savaş Taşoğlu · 2023 · ACS Omega
97. Production of α1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning
    Hanchao Gao, Chengjiang Zhao, Xi XIANG, Yong Li, Yanli Zhao, Zesong Li, Dengke Pan, Yifan Dai, Hidetaka Hara, David K. C. Cooper et al. · 2016 · Journal of Reproduction and Development
98. CRISPR–Cas9 in genome editing: Its function and medical applications
    Saedeh Khadempar, Shokoufeh Familghadakchi, Roozbeh Akbari Motlagh, Najma Farahani, Maryam Dashtiahangar, Hamzeh Rezaei, Seyed Mohammad Gheibi Hayat · 2018 · Journal of Cellular Physiology
99. Impact of CRISPR interference on strain development in biotechnology
    Kerstin Schultenkämper, Luciana Fernandes Brito, Volker F. Wendisch · 2020 · Biotechnology and Applied Biochemistry
100. CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants
     Abdullah Abdullah, Zhengzheng Jiang, Xulin Hong, Shun Zhang, Ruilian Yao, Yi Xiao · 2020 · Synthetic and Systems Biotechnology